SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-14-002030
Filing Date
2014-11-03
Accepted
2014-11-03 12:05:16
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.DEERFIELD SPEC

Document Format Files

Seq Description Document Type Size
1 e612808_sc13g-synergy.htm SC 13G 584286
  Complete submission text file 0001193805-14-002030.txt   586193
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Subject) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86352 | Film No.: 141188499
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G